Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2017; 71(4): 293–298. doi:10.14735/amgh2017293.

Serum concentration of S100P protein in patients with colorectal cancer

Paula Morávková1, Darina Kohoutová1, Marcela Drahošová Orcid.org  , Jan Bureš Orcid.org  2

+ Affiliation

Summary

Background: Colorectal cancer (CRC) is the third most frequent cancer worldwide and in the Czech Republic. S100P protein plays a significant role in colorectal carcinogenesis and in tumour metastatic progression. The aim of this prospective study was to assess the association between serum concentration of S100P protein and CRC. Methods: The study included 79 subjects – 36 controls and 43 patients with CRC. The CRC group was divided into subgroups according to tumour side (13 patients with right-sided CRC (CRC-R group) and 30 patients with left-sided CRC (CRC-L group)); stage of the disease (9 patients in clinical stage I, 7 in stage II, 13 in stage III and 13 in stage IV); and tumour grading (5 patients with well-differentiated tumour (G1), 24 patients with moderately-differentiated tumour (G2) and 11 patients with poorly-differentiated tumour (G3)). Serum concentrations of S100P protein were measured in peripheral blood samples using ELISA. Results: Serum S100P was significantly higher in the CRC group (median: 1251; inter-quartile range (IQR): 731–1749 ng/L) than in the controls (median: 765; IQR: 545–1158 ng/L); p = 0.012. Compared to the control group, serum S100P was significantly higher in patients with left-sided tumours (median: 1426; IQR: 739–1925 ng/L; p = 0.005), in clinical stage IV (median: 1622; IQR: 778–2154 ng/L;
p = 0.008) and in patients with moderately-differentiated tumours (median: 1318; IQR: 853–1879 ng/L; p = 0.005). No difference was observed in the CRC-R group when compared with the controls and CRC-L group; p > 0.05. Conclusion: The study confirms a relationship between serum concentration of S100P protein and CRC. Significantly higher serum levels were observed in patients in clinical stage IV and patients with left-sided carcinoma.

Keywords

S100P, biomarker, colorectal cancer

Literature

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (5): E359–E386. doi: 10.1002/ijc.29210.
2. Gregor J, Malúšková D, Mužík J et al. Epidemiologie kolorektálního karcinomu v České republice. [online]. Dostupné z: www.kolorektum.cz/index.php?pg=pro-odborniky-epidemiologie-kolorektalniho-karcinomu-epidemiologie-kolorektalniho-karcinomu-v-cr.
3. Mužík J, Dušek L, Šnajdrová L. Epidemiologie kolorektálního karcinomu v krajích České republiky. [online]. Dostupné z: www.kolorektum.cz/index.php?pg=pro-odborniky-epidemiologie-kolorektalniho-karcinomu-epidemiologie-kolorektalniho-karcinomu-v-krajich-ceske-republiky.
4. SVOD. Epidemiologie zhoubných nádorů v České republice. [online]. Dostupné z: www.svod.cz.
5. Moore BW, McGregor D. Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver. J Biol Chem 1965; 240: 1647–1653.
6. Moravkova P, Kohoutova D, Rejchrt S et al. Role of S100 Proteins in Colorectal  Carcinogenesis. Gastroenterology Res  Pract 2016; 2016: 2632703. doi: 10.1155/ 2016/2632703.
7. Becker T, Gerke V, Kube E et al. S100P, a novel Ca (2+) -binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties. Eur J Biochem 1992; 207 (2):  541–547.
8. Emoto Y, Kobayashi R, Akatsuka H et al. Purification and characterization of a new member of the S-100 protein family from human placenta. Biochem Biophys Res Commun 1992; 182 (3): 1246–1253.
9. Jin G, Wang S, Hu X et al. Characterization of the tissue-specific expression of the s100P gene which encodes an EF-hand Ca2+-binding protein. Mol Biol Rep 2003; 30 (4): 243–248.
10. Parkkila S, Pan P, Ward A et al. The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol 2008; 8: 2. doi: 10.1186/1472-6890-8-2.
11. Koltzscher M, Neumann C, König S et al. Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P. Mol Biol Cell 2003; 14 (6): 2372–2384.
12. Austermann J, Nazmi AR, Müller-Tidow C et al. Characterization of the Ca2+-regulated ezrin-S100P interaction and its role in tumor cell migration. J Biol Chem 2008; 283 (43): 29331–29340. doi: 10.1074/jbc.M806145200.
13. Arumugam T, Simeone DM, Schmidt AM et al. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 2004; 279 (7): 5059–5065.
14. Penumutchu SR, Chou RH, Yu C. Structural insights into calcium-bound S100P and the V domain of the RAGE complex. PLoS One 2014; 9 (8): e103947. doi: 10.1371/journal.pone.0103947.
15. Mercado-Pimentel ME, Onyeagucha BC, Li Q et al. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. FEBS letters 2015; 589 (18): 2388–2393. doi: 10.1016/j.febslet. 2015.07.010.
16. Chandramouli A, Mercado-Pimentel ME, Hutchinson A et al. The induction of S100P expression by the Prosta-glandin E2 (PGE2) /EP4 receptor signal-ing pathway in colon cancer cells. Cancer Biol Ther 2010; 10 (10): 1056–1066. doi: 10.4161/cbt.10.10.13373.
17. Lin F, Zhang P, Zuo Z et al. Thioredoxin-1 Promotes Colorectal Cancer Invasion and Metastasis through Crosstalk with S100P. Cancer Lett 2017; 401: 1–10. doi: 10.1016/j.canlet.2017.04. 036.
18. Birkenkamp-Demtroder K, Olesen SH, Sørensen FB et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005; 54 (3): 374–384.
19. Fuentes MK, Nigavekar SS, Arumu-gam T et al. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 2007; 50 (8): 1230–1240.
20. Li JN, Zhao L, Wu J et al. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer. J Dig Dis 2012; 13 (1): 24–32. doi: 10.1111/j.1751-2980.2011.00551.x.
21. Dong L, Wang F, Yin X et al. Overexpression of S100P promotes colorectal cancer metastasis and decreases chemosen-sitivity to 5-FU in vitro. Mol Cell Biochem 2014; 389 (1–2): 257–264. doi: 10.1007/ s11010-013-1947-5.
22. Weidle UH, Birzele F, Krüger A. Molecular targets and pathways involved in liver metastasis of colorectal cancer. Clin Exp Metastasis 2015; 32 (6): 623–635. doi: 10.1007/s10585-015-9732-3.
23. Shen ZY, Fang Y, Zhen L et al. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma. Cancer Genet 2016; 209 (4): 143–153. doi: 10.1016/j.cancergen.2016.02.002.
24. Royse KE, Chen L, Berger DH et al. Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma. Int J Mol Epidemiol Genet 2017; 8 (2): 8–18.
25. Wang Q, Zhang YN, Lin GL et al. S100P, a potential novel prognostic marker in colorectal cancer. Oncol Rep 2012; 28 (1): 303–310. doi: 10.3892/or.2012.1794.
26. Benson AB 3rd, Venook AP, Ceder-quist L et al. Colon Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. [online]. Available from: www.nccn.org/professionals/physician_gls/pdf/colon_blocks.pdf.
27. Diederichs S, Bulk E, Steffen B et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 2004; 64 (16): 5564–5569.
28. Mousses S, Bubendorf L, Wagner U et al. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 2002; 62 (5): 1256–1260.
29. Schor AP, Carvalho FM, Kemp C et al. S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep 2006; 15 (1): 3–6.
30. Wang G, Platt-Higgins A, Carroll J et al. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 2006; 66 (2): 1199–1207.
31. Ji J, Zhao L, Wang X et al. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004; 130 (8): 480–486.
32. Liang J, Luo G, Ning X et al. Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein. Biochem Cell Biol 2007; 85 (3): 375–383.
33. Logsdon CD, Simeone DM, Binkley C et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63 (10): 2649–2657.
34. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003; 201 (1): 63–74.

Credited self-teaching test